Bangladesh Measles Outbreak: Vaccination Gaps, Travel Fuel Crisis
Bangladesh is grappling with one of its deadliest measles outbreaks in decades, driven by significant vaccination coverage gaps and increased travel. Health authorities and international partners are implementing emergency vaccination campaigns to contain the rapidly spreading, highly contagious disease.
Key Highlights
- Bangladesh faces severe measles outbreak, deadliest in decades.
- Declined vaccination coverage and travel contribute to crisis.
- Tens of thousands suspected cases, hundreds of child deaths reported.
- Political instability in 2024 disrupted vaccination efforts.
- Emergency vaccination campaigns launched with WHO and UNICEF support.
- Outbreak highlights critical immunity gaps among children.
Bangladesh is currently battling one of its most severe measles outbreaks in decades, a health crisis exacerbated by significant gaps in vaccination coverage and increased population mobility. The South China Morning Post article, published on June 2, 2026, accurately highlights the ongoing risk and the contributing factors of insufficient vaccinations and travel. This narrative is strongly corroborated by various credible sources, including the World Health Organization (WHO) and UNICEF.
The outbreak has demonstrated a concerning scale, with suspected cases and fatalities escalating significantly throughout 2026. Initially, as of March 2026, UNICEF reported 676 confirmed infections and over 38 child deaths. By mid-April 2026, WHO noted 19,161 suspected cases and 2,897 laboratory-confirmed cases between March 15 and April 14, alongside 166 suspected measles-related deaths. News reports from early June 2026, around the time the SCMP article was published, indicated over 60,000 suspected cases and nearly 600 deaths since mid-March. CIDRAP further reported nearly 71,000 infections and 585 fatalities by June 1, 2026. The numbers continued to climb, with BBC News reporting nearly 750 deaths and over 120,000 suspected and confirmed cases since mid-March by July 9, 2026, with almost 1,000 new cases daily. As of August 4, 2026, the Directorate General of Health Services (DGHS) reported 131,946 suspected cases, 16,531 confirmed infections, and at least 849 child deaths, making it the world's largest outbreak by case count at that time.
A primary driver of this resurgence is a substantial decline in Measles-Rubella (MR) vaccine coverage. WHO reports a nationwide stockout of MR vaccine between 2024 and 2025, coupled with routine immunization gaps and the absence of regular nationwide supplementary MR campaigns since 2020, which collectively increased the number of susceptible children. Political instability in 2024, including student-led protests that overthrew the government, caused delays and even cancellation of planned vaccination drives, further worsening immunity gaps. Some reports even linked poor decisions by an interim administration in power until February 2026, including allegations of a push to privatise vaccination, to vaccine shortages. Consequently, vaccine coverage dropped significantly, with some estimates indicating a fall from around 90% in 2020 to roughly 57% in 2025.
Travel has played a critical role in the rapid spread of the disease. The SCMP article specifically mentions travel as a risk factor. Concerns were particularly heightened after the Eid al-Adha holiday in June 2026, when millions of Bangladeshis traveled to their hometowns, creating a high risk for further transmission without adequate public health mitigation measures. This unchecked movement facilitated the spread of the highly contagious virus across the country, affecting 58 out of 64 districts and concentrating cases in densely populated informal settlements in major cities like Dhaka, Rajshahi, Chattogram, and Khulna.
The outbreak disproportionately affects young children, with the majority (79%) of reported cases occurring among those under five years old. Many infants too young for routine vaccination (under nine months) have also been infected. The severe complications of measles include hearing loss, pneumonia, brain damage, and death, placing immense strain on the healthcare system, with hospitals reportedly running out of beds.
In response to the escalating crisis, the Government of Bangladesh, with substantial support from UNICEF, WHO, Gavi, the Vaccine Alliance, and the United States, launched emergency measles-rubella vaccination campaigns. A targeted campaign began on April 5, 2026, prioritizing over 1.2 million children aged 6 months to 5 years in 30 high-risk upazilas and 18 districts. This was followed by a phased nationwide rollout from April 20, 2026, aiming to vaccinate 18 million children. Efforts are also underway to strengthen nationwide surveillance and epidemiological analysis to enhance case detection and reporting. While significant progress has been made in inoculating a high percentage of the target population, the ongoing transmission underscores the urgent need to close immunity gaps to prevent continued spread.
Frequently Asked Questions
What is causing the severe measles outbreak in Bangladesh?
The severe measles outbreak in Bangladesh is primarily caused by significant gaps in measles-rubella (MR) vaccination coverage. This includes nationwide vaccine stockouts between 2024-2025, disruptions to routine immunization, and the absence of supplementary vaccination campaigns since 2020. Political instability in 2024 also delayed crucial vaccination drives. Additionally, widespread travel, particularly during holidays like Eid al-Adha, has facilitated the rapid spread of the highly contagious virus.
How many cases and deaths have been reported in the Bangladesh measles outbreak?
The number of reported cases and deaths has varied and increased over time. As of early June 2026, there were over 60,000 suspected cases and nearly 600 deaths since mid-March. By July 9, 2026, reports indicated nearly 750 deaths and over 120,000 suspected and confirmed cases. The Directorate General of Health Services (DGHS) reported 131,946 suspected cases, 16,531 confirmed infections, and at least 849 child deaths by August 4, 2026.
Which population group is most affected by the measles outbreak?
The measles outbreak predominantly affects young children, with the majority (approximately 79%) of reported cases occurring among children under five years of age. This includes many infants who are too young to have received their routine vaccinations, highlighting critical immunity gaps within this vulnerable population.
What measures are being taken to control the measles outbreak in Bangladesh?
The Government of Bangladesh, supported by international organizations like UNICEF, WHO, and Gavi, the Vaccine Alliance, has launched emergency measles-rubella vaccination campaigns. These campaigns began in April 2026, initially targeting over 1.2 million children in high-risk areas and then expanding nationwide to reach 18 million children. Efforts also include strengthening surveillance and epidemiological analysis to improve case detection and reporting.
What is the risk of the Bangladesh measles outbreak spreading to neighboring countries like India?
While the article primarily focuses on Bangladesh, any large-scale outbreak in a neighboring country poses a potential risk for cross-border transmission, especially given the high population density and frequent movement of people in the South Asia region. Public health authorities in neighboring countries typically heighten surveillance and preparedness in such scenarios. The scale of this outbreak highlights a global concern about measles resurgence when vaccination rates fall below critical thresholds.
